Physician profile
Khanh Vu
NPI 1679570717
$8,882.97
in general payments reported to CMS, 2019-2025
61 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $1,075 · 2021: $1,395 · 2022: $896 · 2023: $1,393 · 2024: $1,447 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,789.77 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $823.09 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $739.54 | 2019-2025 | |
| Abbvie INC. | $679.58 | 2020-2025 | Ubrelvy, Vraylar, Liletta |
| Glaxosmithkline, LLC. | $542.00 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $519.81 | 2019-2024 | |
| Lilly USA, LLC | $376.04 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $374.41 | 2019-2022 | |
| Sanofi Pasteur INC. | $211.52 | 2019-2025 | |
| Esperion Therapeutics, INC. | $194.86 | 2020-2021 | |
| Medtronic, INC. | $180.50 | 2024 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.98 | 2019-2024 | Xifaxan |
| Astellas Pharma US INC | $121.35 | 2019-2025 | Veozah |
| Somnomed INC. | $115.71 | 2024 | |
| Recordati_rare_diseases_inc. | $112.00 | 2025 | Panhematin |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khanh Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.